412 related articles for article (PubMed ID: 18164198)
1. Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor.
Boojamra CG; Mackman RL; Markevitch DY; Prasad V; Ray AS; Douglas J; Grant D; Kim CU; Cihlar T
Bioorg Med Chem Lett; 2008 Feb; 18(3):1120-3. PubMed ID: 18164198
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-HIV activity of 2'-fluorine modified nucleoside phosphonates: analogs of GS-9148.
Mackman RL; Lin KY; Boojamra CG; Hui H; Douglas J; Grant D; Petrakovsky O; Prasad V; Ray AS; Cihlar T
Bioorg Med Chem Lett; 2008 Feb; 18(3):1116-9. PubMed ID: 18082402
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates.
Mackman RL; Boojamra CG; Prasad V; Zhang L; Lin KY; Petrakovsky O; Babusis D; Chen J; Douglas J; Grant D; Hui HC; Kim CU; Markevitch DY; Vela J; Ray A; Cihlar T
Bioorg Med Chem Lett; 2007 Dec; 17(24):6785-9. PubMed ID: 18029175
[TBL] [Abstract][Full Text] [Related]
5. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
[TBL] [Abstract][Full Text] [Related]
6. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2009 Apr; 6(4):561-8. PubMed ID: 19353537
[TBL] [Abstract][Full Text] [Related]
7. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
Mai A; Artico M; Ragno R; Sbardella G; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; Maga G; La Colla P
Bioorg Med Chem; 2005 Mar; 13(6):2065-77. PubMed ID: 15727860
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-HIV activity of cyclic pyrimidine phosphonomethoxy nucleosides and their prodrugs: a comparison of phosphonates and corresponding nucleosides.
Mackman RL; Zhang L; Prasad V; Boojamra CG; Chen J; Douglas J; Grant D; Laflamme G; Hui H; Kim CU; Parrish J; Stoycheva AD; Swaminathan S; Wang K; Cihlar T
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):573-7. PubMed ID: 18066858
[TBL] [Abstract][Full Text] [Related]
10. Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Cesarini S; Spallarossa A; Ranise A; Schenone S; Bruno O; La Colla P; Casula L; Collu G; Sanna G; Loddo R
Bioorg Med Chem; 2008 Jun; 16(12):6353-63. PubMed ID: 18502646
[TBL] [Abstract][Full Text] [Related]
11. Aryl nucleoside H-phosphonates. Part 16: synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters.
Romanowska J; Szymańska-Michalak A; Boryski J; Stawiński J; Kraszewski A; Loddo R; Sanna G; Collu G; Secci B; La Colla P
Bioorg Med Chem; 2009 May; 17(9):3489-98. PubMed ID: 19282192
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
[TBL] [Abstract][Full Text] [Related]
14. Aryl H-phosphonates 17: (N-aryl)phosphoramidates of pyrimidine nucleoside analogues and their synthesis, selected properties, and anti-HIV activity.
Romanowska J; Sobkowski M; Szymańska-Michalak A; Kołodziej K; Dąbrowska A; Lipniacki A; Piasek A; Pietrusiewicz ZM; Figlerowicz M; Guranowski A; Boryski J; Stawiński J; Kraszewski A
J Med Chem; 2011 Oct; 54(19):6482-91. PubMed ID: 21834513
[TBL] [Abstract][Full Text] [Related]
15. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
[TBL] [Abstract][Full Text] [Related]
16. An HIV reverse transcriptase-selective nucleoside chain terminator.
Fraley AW; Chen D; Johnson K; McLaughlin LW
J Am Chem Soc; 2003 Jan; 125(3):616-7. PubMed ID: 12526645
[TBL] [Abstract][Full Text] [Related]
17. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
18. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design, synthesis, and in vitro assay of novel nucleoside analog inhibitors against HIV-1 reverse transcriptase.
Liu X; Xie W; Huang RH
Bioorg Med Chem Lett; 2005 Aug; 15(16):3775-7. PubMed ID: 15993595
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of phosphonated dihydroisoxazole nucleosides.
Romeo G; Iannazzo D; Piperno A; Romeo R; Saglimbeni M; Chiacchio MA; Balestrieri E; Macchi B; Mastino A
Bioorg Med Chem; 2006 Jun; 14(11):3818-24. PubMed ID: 16480883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
